Painaustralia policy

TGA submission re: Modified Release paracetamol

Painaustralia and our members are supportive of the rescheduling of slow release (MR) paracetamol, from Schedule 2 to Schedule 3, and the correction of terminology from slow release to modified release to accurately reflect the formulation of these products.

In implementing these changes, Painaustralia recommends the upscheduling be supported by targeted consumer education around quality use of paracetamol and evaluated in 12 months to assess the impact on consumer access.

Painaustralia is also recommending the National Strategic Action Plan on Pain Management be implemented to ensure consumers and health professionals have a better understanding of pain management and that training, education and supports and services are in place to support these regulatory changes.